Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria (Q47799946)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria |
scientific article |
Statements
1 reference
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria (English)
1 reference
Southwest Oncology Group
1 reference
Bradley Monk
1 reference
David Alberts
1 reference
Maurie Markman
1 reference
P Y Liu
1 reference
Sharon Wilczynski
1 reference
Larry J Copeland
1 reference
Ronald D Alvarez
1 reference
Caroline Jiang
1 reference
Gynecologic Oncology Group
1 reference
1 July 2003
1 reference
21
1 reference
13
1 reference
2460-2465
1 reference